There has been a reported breakthrough in the race to develop a Covid-19 vaccine by scientists at Oxford University. An immune response to the new vaccine called ChAdOx1 nCoV-19 has indicated a strong “double defence”, whereby both antibodies and “killer” T-cells were reported to have been present in blood samples from volunteers in the first human phase of testing. The information was provided to The Telegraph by a senior source. Further media coverage will be reported on these developments on Monday 20th July.
Latest posts by Hippocratic Post (see all)
- International Day of Play 2025 - 9th June 2025
- Urgent EU Action to Safeguard Access to Medicines - 8th June 2025
- Common gene variant doubles dementia risk for men - 8th June 2025